Sep 2026· World Journal of Stem Cells· 0 citations· 69 references
TL;DR
This review introduces the sources and isolation methods of stem cells for lung organoid generation, describes preparation processes, and evaluates the utility of lung organoids in building pulmonary disease models, distinguishing between current validated applications and proposed future capabilities.
Abstract
Pulmonary diseases impose a substantial global burden and remain major causes of morbidity and mortality. Despite advances in disease-modifying therapies, effective regenerative treatments remain limited for several chronic lung diseases, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Stem cell-based therapies have shown promise in preclinical studies and early-phase clinical trials for lung tissue repair; however, substantial obstacles remain before clinical translation, including incomplete understanding of therapeutic mechanisms, safety concerns regarding tumorigenicity and immunogenicity, and a lack of standardized evaluation platforms. Lung organoids are three-dimensional, in vitro tissue constructs derived from pluripotent or adult stem cells that may bridge basic stem cell research and clinical application. This review introduces the sources and isolation methods of stem cells for lung organoid generation, describes preparation processes, and evaluates the utility of lung organoids in building pulmonary disease models. Importantly, we distinguish between current validated applications and proposed future capabilities. Organoid-based evidence offers new directions for investigating pathological mechanisms in stem cell treatment and suggests the exploratory potential of organoids in drug screening and early toxicity testing. However, direct evidence for the validation of stem cell therapies using human lung organoids is limited; most supporting data come from small-scale animal studies or proof-of-concept experiments. In addition, much of the evidence remains preclinical and model-dependent, with current organoid systems lacking vascularization, innervation, systemic circulation, and a complete immune context. Finally, we summarize the validated applications of lung organoids in stem cell therapy assessment (mechanistic elucidation and donor-specific screening), identify the remaining experimental gaps (clinical predictive validity, long-term safety surrogates), and propose the evidence needed to address these limitations.
A comprehensive literature review of preclinical models and clinical trials focusing on mesenchymal, hematopoietic, and pluripotent stem cells, evaluating their efficacy, safety, and manufacturing challenges found stem cell therapies demonstrate remarkable healing potential.
Somayeh Shamlou, H. Rostami, Ali Hassanzadeh et al.· Journal of Clinical and Tran...· 0 citations
This review provides a comprehensive framework for developing safer, standardized, and clinically transformative therapies based on MSCs, and explores emerging strategies to enhance the activity of MSCs, including pretreatment and activation, lifestyle intervention, and genetic engineering techniques.
Dong-Mei Xue, Yong-Sheng Li, Lei Wu· MedComm· 0 citations
Organoids are three‐dimensional multicellular structures derived from stem cells or primary tissues that recapitulate key structural and functional features of native organs. Advances in stem cell biology, biomaterials, and bioengineering have established organoids as powerful platforms for studying human development a...
Yue-Qi Leng, Yue Wang, C. Cao et al.· MedComm· 0 citations
This review summarizes recent advances in 3D cardiac in vitro modeling technologies, outlines major cardiac model construction strategies and their technical characteristics, and discusses their applications in drug toxicity evaluation, high-throughput drug screening, disease modeling, and personalized medicine.
Xiao-Ying Liu, Ying-Juan Liu, Yu-Tong Yan et al.· International Journal of Dru...· 0 citations
Stem cell‐based therapies are rapidly reshaping dermatology, driven by advances in regenerative medicine, tissue engineering, and molecular therapeutics. The skin, with its intrinsic regenerative capacity and well‐defined stem cell niches, represents a uniquely accessible model for translational application....
N. Akhoon, Aseem Sharma, R. Kaul· Dermatological Reviews· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.